Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway.
Center for Crisis Psychology, Faculty of Psychology, University of Bergen, Bergen, Norway.
BMC Psychiatry. 2023 Aug 8;23(1):570. doi: 10.1186/s12888-023-05062-7.
The Bergen 4-day treatment (B4DT) is a concentrated exposure-based therapy that has been shown to be effective in the treatment of anxiety disorders. The current study sought to examine the effectiveness of B4DT for panic disorder (PD), when delivered with a combination of face-to-face sessions and videoconferencing.
Treatment was delivered to 50 patients from April 2020 to May 2021. Because of regulations during the pandemic, a significant portion of the treatment was conducted via videoconference. The primary outcome measure was the clinician-rated Panic Disorder Severity Scale (PDSS), and secondary measures included patient-rated symptoms of panic disorder, agoraphobia, generalized anxiety, depression, and treatment satisfaction. Changes in symptom levels over time were estimated using multilevel models.
Patients showed a significant reduction in clinician-rated symptoms of panic disorder (Measured by PDSS) from before treatment to post treatment (d = 2.18) and 3-month follow-up (d = 2.01). At three months follow-up 62% of patients were classified as in remission, while 70% reported a clinically significant response. We also found a reduction in symptoms of depression and generalized anxiety, and the patients reported high satisfaction with the treatment.
The current study suggests that B4DT delivered in a combination of videoconference and face-to-face meetings may be a useful treatment approach. As the study is uncontrolled, future studies should also include more strictly designed investigations.
卑尔根 4 天治疗（B4DT）是一种集中暴露为基础的治疗，已被证明在治疗焦虑症方面有效。目前的研究旨在检查 B4DT 在面对面会议和视频会议相结合的情况下治疗惊恐障碍（PD）的有效性。
治疗于 2020 年 4 月至 2021 年 5 月期间提供给 50 名患者。由于大流行期间的规定，治疗的很大一部分是通过视频会议进行的。主要的结局测量是临床医生评定的惊恐障碍严重程度量表（PDSS），次要测量包括患者评定的惊恐障碍、广场恐怖症、广泛性焦虑、抑郁和治疗满意度的症状。使用多层次模型估计症状水平随时间的变化。
患者的惊恐障碍临床症状（通过 PDSS 测量）从治疗前到治疗后（d=2.18）和 3 个月随访（d=2.01）显著降低。在三个月的随访中，62%的患者被归类为缓解，而 70%的患者报告有临床显著反应。我们还发现抑郁和广泛性焦虑的症状减轻，患者对治疗的满意度很高。
目前的研究表明，在视频会议和面对面会议相结合的情况下进行的 B4DT 可能是一种有用的治疗方法。由于该研究是非对照的，未来的研究也应包括更严格设计的调查。
